ASHLEIGH BOYINGTON: Open Payments
NPI 1851931521 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 21 payments from 6 companies in 2025. Trend: 2023 $90 · 2024 $521 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $113 |
| SANOFI-AVENTIS U.S. LLC | 5 | $112 |
| Alpha Cognition USA, Inc. | 1 | $95 |
| Lilly USA, LLC | 4 | $85 |
| Exact Sciences Corporation | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
Products named: TZIELD, Wegovy, Zunveyl, MOUNJARO, The Cologuard Plus Collection Kit, REXULTI, Ozempic.
Industry payments across AL — which companies pay providers there.
